Results 181 to 190 of about 3,269,992 (265)

Efficacy and Safety of Nifedipine as a Tocolytic Agent in Preterm Labor

Neelam Nalini, Anika Kujur, Bijeta Singh, Kshitij Aviraj Singh   +3 more
openalex   +1 more source

Metabolomic characteristics of cord blood from neonates with hyperkalemia after antenatal exposure to ritodrine and magnesium sulfate. [PDF]

Sci Rep
Inoue M, Sekiguchi K, Tsushita H, Inoue N, Maeda T, Itoh H, Ihara K.   +6 more
europepmc   +1 more source

Placenta Prévia: Classificação e Orientação Terapêutica [PDF]

, 2012
Maria Isabel Bento Ayres Pereira
core  

Risk Factors and a Preliminary Clinical Prediction Model for Postpartum Hemorrhage or the Need for Hemostatic Intervention in Twin Cesarean Deliveries. [PDF]

Int J Womens Health
Lei ZL.
europepmc   +1 more source

Abortifacient Drugs and Devices: Medical and Moral Dilemmas [PDF]

, 1990
Severyn, Kristine M.
core   +1 more source

In vitro and in silico dynamic analysis of alkaloid extract of Moringa oleifera leaf as a Tocolytic agent

Ofioritse Ogheneyoma Ofulue, Isoken M. Ebomoyi, Adaeze P. Uchendu   +2 more
openalex   +1 more source

A disproportionality analysis of nifedipine in the overall population and in pregnant women using the FDA Adverse Event Reporting System (FAERS) database. [PDF]

Medicine (Baltimore)
Ju G, Chen L, Wang R, Zhang L, Liu Z, Chen S.   +5 more
europepmc   +1 more source

Anesthetic challenges in using posterior retroperitoneoscopic approach for phaeochromocytoma in pregnancy. [PDF]

J Anaesthesiol Clin Pharmacol
Kumar N, Shreehari R, Jha CK.
europepmc   +1 more source

Tocolysis and Neurodevelopment of Children Born Very Preterm.

JAMA Netw Open
Plouchart T, Sabatier T, Muller JB, Pinto Cardoso G, Sentilhes L, Bénichou J, Marret S.   +6 more
europepmc   +1 more source

Atosiban versus placebo in the treatment of threatened preterm birth between 30 and 34 weeks gestation: study protocol of the 4-year APOSTEL 8 follow-up. [PDF]

BMJ Open
van der Windt L, Klumper J, van Limburg Stirum EVJ, van 't Hooft J, van Wely M, van Wassenaer-Leemhuis AG, Pajkrt E, Oudijk MA, APOSTEL 8 Study Group.   +8 more
europepmc   +1 more source